Figure 3

Analysis of multiple ovarian cancer samples and therapy outcomes. (A) Human epidermal growth factor receptor 2 (HER2) expression in each anatomic location stratified by HER2 expression. (B) Changes in HER2 expression among patients with time-lagged biopsies. (C) Swimmer plot showing outcomes of HER2-targeted therapies with BRCA, mismatch repair protein (MMR), and programmed cell death ligand 1 (PD-L1) status.